Abbott LaboratoriesAbbott LaboratoriesAbbott Laboratories

Abbott Laboratories

No trades
No trades

Compare with Abbott Laboratories


Market capitalization
‪186.81 B‬USD
3.11USD
‪6.50 B‬USD
‪44.33 B‬USD
‪1.72 B‬
Beta (1Y)
−0.32
Next report date
Report period
EPS estimate
Revenue estimate
Employees (FY)
‪115 K‬
Change (1Y)
‪+1 K‬+0.88%
Revenue / Employee (1Y)
‪385.46 K‬USD
Net income / Employee (1Y)
‪56.52 K‬USD

Details


CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Founded
1888
IPO date
Mar 1, 1937
ISIN
US0028241000
CUSIP
002824100
FIGI
BBG000B9ZXB4
Identifiers
ISIN US0028241000
CFI code
ESVUFR
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateMar 15, 2066
Coupon5.60% (Fixed)
Maturity dateMar 15, 2056
Coupon5.50% (Fixed)
Maturity dateNov 30, 2046
Coupon4.90% (Fixed)
Maturity dateApr 15, 2043
Coupon4.75% (Fixed)
Maturity dateMay 27, 2040
Coupon5.30% (Fixed)
Maturity dateMar 15, 2038
Coupon4.75% (Fixed)
Maturity dateApr 1, 2039
Coupon6.00% (Fixed)
Maturity dateNov 30, 2037
Coupon6.15% (Fixed)
Maturity dateMar 15, 2036
Coupon4.65% (Fixed)
Maturity dateNov 30, 2036
Coupon4.75% (Fixed)
Maturity dateMar 15, 2033
Coupon4.30% (Fixed)

See all ABT bonds 

Weight0.22%
Market value‪5.02 B‬
Weight4.74%
Market value‪4.99 B‬
Weight0.24%
Market value‪4.11 B‬
Weight0.28%
Market value‪2.55 B‬
Weight0.28%
Market value‪2.28 B‬
Weight0.59%
Market value‪1.50 B‬
Weight3.17%
Market value‪1.36 B‬
Weight0.69%
Market value‪892.91 M‬
Weight0.65%
Market value‪627.66 M‬
Weight18.44%
Market value‪618.40 M‬
Weight1.11%
Market value‪481.12 M‬

Explore more ETFs 

Frequently asked questions


The current price of ABT is 107.81 USD — it has decreased by −0.55% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Abbott Laboratories stocks are traded under the ticker ABT.
ABT stock has risen by 2.79% compared to the previous week, the month change is a 12.89% rise, over the last year Abbott Laboratories has showed a −17.80% decrease.
We've gathered analysts' opinions on Abbott Laboratories future price: according to them, ABT price has a max estimate of 135.00 USD and a min estimate of 103.00 USD. Watch ABT chart and read a more detailed Abbott Laboratories stock forecast: see what analysts think of Abbott Laboratories and suggest that you do with its stocks.
ABT reached its all-time high on Dec 27, 2021 with the price of 142.60 USD, and its all-time low was 0.11 USD and was reached on Oct 4, 1974. View more price dynamics on ABT chart.
See other stocks reaching their highest and lowest prices.
ABT stock is 1.85% volatile and has beta coefficient of −0.32. Track Abbott Laboratories stock price on the chart and check out the list of the most volatile stocks — is Abbott Laboratories there?
Today Abbott Laboratories has the market capitalization of ‪186.81 B‬, it has increased by 6.66% over the last week.
Yes, you can track Abbott Laboratories financials in yearly and quarterly reports right on TradingView.
Abbott Laboratories is going to release the next earnings report on Oct 21, 2026. Keep track of upcoming events with our Earnings Calendar.
ABT earnings for the last quarter are 1.31 USD per share, whereas the estimation was 1.28 USD resulting in a 2.56% surprise. The estimated earnings for the next quarter are 1.42 USD per share. See more details about Abbott Laboratories earnings.
Abbott Laboratories revenue for the last quarter amounts to ‪12.59 B‬ USD, despite the estimated figure of ‪12.52 B‬ USD. In the next quarter, revenue is expected to reach ‪12.99 B‬ USD.
ABT net income for the last quarter is ‪928.00 M‬ USD, while the quarter before that showed ‪1.08 B‬ USD of net income which accounts for 0.00% change. Track more Abbott Laboratories financial stats to get the full picture.
Yes, ABT dividends are paid quarterly. The last dividend per share was 0.63 USD. As of today, Dividend Yield (TTM)% is 2.30%. Tracking Abbott Laboratories dividends might help you take more informed decisions.
Abbott Laboratories dividend yield was 1.92% in 2025, and payout ratio reached 64.54%. The year before the numbers were 1.98% and 29.33% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Aug 7, 2026, the company has ‪115 K‬ employees. See our rating of the largest employees — is Abbott Laboratories on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Abbott Laboratories EBITDA is ‪11.11 B‬ USD, and current EBITDA margin is 25.67%. See more stats in Abbott Laboratories financial statements.
Like other stocks, ABT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Abbott Laboratories stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Abbott Laboratories technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Abbott Laboratories stock shows the neutral signal. See more of Abbott Laboratories technicals for a more comprehensive analysis.